Randomized, double-blind trial of telbivudine versus lamivudine in adults with decompensated chronic hepatitis B and evidence of cirrhosis.

Trial Profile

Randomized, double-blind trial of telbivudine versus lamivudine in adults with decompensated chronic hepatitis B and evidence of cirrhosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2014

At a glance

  • Drugs Telbivudine (Primary) ; Lamivudine
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Apr 2010 Two-year results were reported in an oral session at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) held in Vienna, Austria, on 14th-18th Apr 2010.
    • 30 Mar 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
    • 30 Mar 2010 Planned number of patients (232) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top